Shanghai Kaibao Pharmaceutical's wholly-owned subsidiary obtained a drug registration certificate.

10/03/2025

GMT Eight

Shanghai Kaibao Pharmaceutical (300039.SZ) announced that its wholly-owned subsidiary, Shanghai Kaibao Pharmaceutical Xinyi (Xinxiang) Pharmaceutical Co., Ltd. (referred to as the "Subsidiary"), recently received the Drug Registration Certificate for Dossotea Tablets issued by the National Medical Products Administration. Dossotea Tablets are used for bronchial asthma, wheezing chronic bronchitis, and other respiratory difficulties caused by bronchial spasms.

GGII estimates that the global shipment volume of lithium batteries for Smart Intellgent Automation Systems by Siasun Robot & Automation will have a compound annual growth rate of over 100% between 2025 and 2030.

S&P 500 component stocks reshuffle: Coinbase (COIN.US) and Applovin (APP.US) were not selected, causing their pre-market stock prices to plummet.

Contact: contact@gmteight.com

Shanghai Kaibao Pharmaceutical's wholly-owned subsidiary obtained a drug registration certificate.

RECOMMEND

US Stock Market Move | The previously announced weight loss drug Cagrisema data caused Novo Nordisk A/S Sponsored ADR Class B (NVO.US) to fall more than 8%.

Three directors and executives of Asia Cuanon Technology (603378.SH) plan to reduce their holdings by a total of no more than 4.038 million shares.

JH EDUCATION (01935): Zhengzhou Institute of Economics and Trade has signed a construction engineering contract with Henan Xianrui Construction Engineering.